瑞科生物－Ｂ：2023年報.pdf

1、 (a joint stock company incorporated in the Peoples Republic of China with limited liability)（於中華人民共和國註冊成立的股份有限公司）Stock Code 股份代號:2179江蘇瑞科生物技術股份有限公司Jiangsu Recbio Technology Co.,Ltd.ANNUAL REPORT2023年報2Corporate Information公司資料5Chairmans Statement主席致辭7Financial Highlights財務摘要8Management Discussion a

2、nd Analysis管理層討論與分析35Biographies of our Directors,Supervisors and Senior Management董事、監事及高級管理層履歷52Directors Report董事會報告96Corporate Governance Report企業管治報告125Independent Auditors Report獨立核數師報告134Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表135Consolidated Stateme

3、nt of Financial Position綜合財務狀況表137Consolidated Statement of Changes in Equity綜合權益變動表139Consolidated Statement of Cash Flows綜合現金流量表141Notes to Financial Statements財務報表附註239Definitions and Glossary of Technical Terms釋義及技術詞彙Contents目錄2Jiangsu Recbio Technology Co.,Ltd.江蘇瑞科生物技術股份有限公司Corporate Informatio

4、n公司資料DIRECTORSExecutive Directors1Dr.LIU Yong(Chairman of the Board and General Manager)Dr.CHEN JianpingMr.LI BuMs.CHEN QingqingNon-Executive Directors2Dr.HONG KunxueDr.ZHOU HongbinDr.ZHANG JiaxinMr.HU HouweiIndependent Non-Executive DirectorsMr.LIANG GuodongDr.XIA LijunProfessor GAO FengProfessor Y

5、UEN Ming FaiSUPERVISORSMs.QIAO Weiwei(Chairwoman)Mr.WANG FeizhouMs.QIAN RantingMs.LIU PingJOINT COMPANY SECRETARIESMs.CHEN QingqingMs.HO Yin KwanAUTHORISED REPRESENTATIVESDr.LIU YongMr.LI Bu1 Ms.CHEN Qingqing was appointed as an executive Director on May 11,2023.2 Mr.ZHAO Hui and Dr.DU Wei resigned

6、as non-executive Directors and members of the Remuneration and Appraisal Committee on March 20,2023;Dr.FENG Tao resigned as a non-executive Director and a member of the Nomination Committee on April 3,2023;Dr.ZHANG Jiaxin and Mr.HU Houwei were appointed as non-executive Directors on May 11,2023.董事執行